高级检索
当前位置: 首页 > 详情页

Differential contributions of adeno- and squamous components in promoting lymphatic metastasis of lung adenosquamous cell carcinoma

| 认领 | 导出 |

文献详情

资源类型:
机构: [1]Department of Thoracic Surgery,The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China [2]Lung Cancer Research Center of Sun Yat-sen University, Guangzhou, Guangdong, China. [3]Department of Cardiothoracic Surgery of East Division, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
出处:
ISSN:

关键词: Lung cancer pulmonary adenosquamous carcinoma lymph node metastasis

摘要:
Background: Pulmonary adenosquamous carcinoma (ASC) is a rare type of lung cancer containing both adenocarcinoma (AC) and squamous cell carcinoma (SCC) cells. To better understand the mechanism by which the AC and SCC components are involved in lymph node metastasis, we evaluated the distribution of these cellular components in both primary ASC tumors and lymph node metastases. Methods: Twenty-two patients with ASC and 142 with AC were admitted to the First Affiliated Hospital of Sun Yat-sen University between July 2006 and July 2012 and underwent surgical resection. Primary ASCs and lymph nodes, with or without metastasis, were assayed immunohistochemically for TTF-1, p63, p40, and VEGF-C. Results: The incidence of lymph node metastasis was higher in patients with ASCs than ACs; however, other features of ASC and AC showed no differences. ASC tumors were positive for TTF-1, p63, and p40; however, these proteins were distributed in different tumor islands in the same tumor. Co-expression was less frequent, but TTF-1 expression was higher in metastatic lymph nodes. Conclusions: ASCs are highly aggressive tumors that metastasize via the lymphatic pathway. The two cellular components of these tumors (AC and SCC) behave independently, with the AC component playing a predominant role in lymphatic invasion. Metastatic lymph nodes should be evaluated immunohistochemically to choose a proper chemotherapeutic strategy in patients with ASCs.

语种:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
第一作者:
第一作者机构: [1]Department of Thoracic Surgery,The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China [2]Lung Cancer Research Center of Sun Yat-sen University, Guangzhou, Guangdong, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Thoracic Surgery,The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China [2]Lung Cancer Research Center of Sun Yat-sen University, Guangzhou, Guangdong, China. [3]Department of Cardiothoracic Surgery of East Division, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China [*]Department of Thoracic Surgery, Cardiothoracic Surgery of East Division, The First Affiliated Hospital, Sun Yat-sen University, Lung Cancer Research Center of Sun Yat-sen University, 58 Zhongshan Road II, Guangzhou 510080, Guangdong, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号